RCI Hospitality Holdings (RICK) Shareholder Investigation: Lawsuit Filed

By Garrett J. Bradley, Esq. and Guillaume Buell, Esq.

Published on June 3, 2019

A class action lawsuit has been filed on behalf of investors of RCI Hospitality Holdings (NASDAQ: RICK). Shareholders who purchased at least 1,000 shares of RICK stock between February 14, 2018 and May 10, 2019, and are interested in learning about participating as a lead plaintiff in the lawsuit, are encouraged to contact the Thornton Law Firm at shareholder@tenlaw.com, or call 617-531-3917 to discuss their rights.

Investors interested in serving as a lead plaintiff have until July 22, 2019 to apply. The lawsuit alleges violations of the federal securities laws, and the class has not yet been certified. Until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the lawsuit, RCI made misleading statements, as well as failed to disclose material adverse facts about the Company’s business and operations. Specifically, RCI allegedly failed to disclose to investors that: (1) the Company engaged in numerous transactions with the CEO, including lending him significant sums of money; (2) these practices were reasonably likely to lead to regulatory scrutiny; (3) as a result of investigations into the Company’s governance, the Company would be unable to timely file its financial statements; and (4) Defendants’ positive statements about the Company’s business were misleading or lacked a reasonable basis. As the news about RCI’s alleged misstatements was revealed, RCI’s stock price fell over $3.00 a share.

If you purchased at least 1,000 shares of RCI Hospitality stock (NASDAQ: RICK) between February 14, 2018 and May 10, 2019, and are interested in learning about serving as a lead plaintiff, please contact the Thornton Law Firm’s shareholder rights team at shareholder@tenlaw.com, or call 617-531-3917. All communications will be treated in a confidential manner.

Thornton Law Firm’s securities attorneys specialize in representing individual shareholders and institutional investors in recovering damages caused by corporate wrongdoing or fraud. Its attorneys have decades of experience litigating securities cases in courts throughout the country and have a proven track record of recovering losses on behalf of shareholders.

Whitestone REIT (WSR) Shareholder Investigation: Lawsuit Filed

By Garrett J. Bradley, Esq. and Guillaume Buell, Esq.

Published on May 31, 2019

A class action lawsuit has been filed on behalf of investors of Whitestone REIT (NYSE: WSR). Shareholders who purchased at least 1,000 shares of WSR stock between May 9, 2018 and February 27, 2019, and are interested in learning about participating as a lead plaintiff in the lawsuit, are encouraged to contact the Thornton Law Firm at shareholder@tenlaw.com, or call 617-531-3917 to discuss their rights.

Investors interested in serving as a lead plaintiff have until June 17, 2019 to apply. The lawsuit alleges violations of the federal securities laws, and the class has not yet been certified. Until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the lawsuit, Whitestone made materially false or misleading statements, or failed to disclose, that: (1) Whitestone lacked effective internal control over financial reporting; (2) Whitestone was incorrectly recognizing assets and liabilities; (3) Whitestone’s financial statements for the fiscal year 2018 were overstating revenues; and (4) Whitestone’s financial statements for the fiscal year 2018 could no longer be relied upon. Whitestone’s stock dropped over 14% when the alleged truth was disclosed to investors.

If you purchased at least 1,000 shares of Whitestone REIT stock (NYSE: WSR) between May 9, 2018 and February 27, 2019, and are interested in learning about serving as a lead plaintiff, please contact the Thornton Law Firm’s shareholder rights team at shareholder@tenlaw.com, or call 617-531-3917. All communications will be treated in a confidential manner.

Thornton Law Firm’s securities attorneys specialize in representing individual shareholders and institutional investors in recovering damages caused by corporate wrongdoing or fraud. Its attorneys have decades of experience litigating securities cases in courts throughout the country and have a proven track record of recovering losses on behalf of shareholders.

Contact Information:

 

Guillaume Buell
Thornton Law Firm LLP
1 Lincoln StreetBoston, Massachusetts 02111 

Email: gbuell@tenlaw.com

Tel: 617-531-3933

 

 

 

Thornton Law Firm Appointed Co-Lead Counsel in Securities Class Action Alleging Misconduct Against Adient plc

By Garrett J. Bradley, Esq. and Guillaume Buell, Esq.

Published on May 15, 2019

Thornton Law Firm has been appointed co-Lead Counsel in a federal securities class action pending against the seat manufacturing company Adient plc, its former CEO, and its CFO. The case is In re Adient plc Securities Litigation., No. 18-cv-9116. The lawsuit is pending in the United States District Court for the Southern District of New York. Thornton Law Firm will aggressively seek to recover investment losses suffered by Adient investors as a result of the Adient defendants’ material misstatements and omissions concerning the Company’s operations and finances. The investigation and lawsuit focuses on misstatements and omissions during the October 2016 to June 2018 time period.

The Thornton Law Firm team litigating this class action is led by attorney Guillaume Buell, who co-chairs the Firm’s securities litigation practice and has an established track record of obtaining favorable results in securities class action. In remarks after the Court’s appointment of Bristol County as Lead Plaintiff and Thornton Law Firm as co-Lead Counsel, Mr. Buell stated: “We look forward to working tirelessly on behalf of the putative class of Adient shareholders the Complaint seeks relief for. Our team is ready to roll up our sleeves and get to work for Adient’s shareholders.” The sentiment was echoed by Thornton Managing Partner Garrett Bradley: “Our Firm is dedicated to investing the resources necessary to investigate this alleged misconduct.”

Thornton Law Firm, based in Boston, Massachusetts and with its second office in Beverly Hills, California, is the preeminent plaintiffs’ law firm in New England. For over four decades, it has tirelessly fought on behalf of injured consumers and shareholders. Its securities litigation team has a proven track record of success in securities litigation. Anyone with questions regarding this litigation, or any other securities or consumer litigation matter, is encouraged to contact the Firm’s class action practice at (617) 720-1333 or shareholder@tenlaw.com. The Firm is presently prosecuting a range of lawsuits arising under the federal securities laws in state and federal courts across the country. For more, visit us at www.tenlaw.com/securities-litigation.

Apple Inc. Shareholder Investigation: Lawsuit Filed (AAPL)

By Garrett J. Bradley Esq. and Guillaume Buell, Esq.

Published on April 26, 2019

Thornton Law Firm LLP announces that it is investigating a securities class action on behalf of shareholders and investors who purchased the securities of Apple Inc. (NASDAQ ticker: AAPL). The investigation involves possible violations of the federal securities laws by Apple, Timothy Cook, and Luca Maestri. A class action has been filed, and if you are an Apple shareholder interested in learning more, please email shareholder@tenlaw.com, or call 617-531-3933.

According to the lawsuit, Apple and the defendants made materially false and misleading statements regarding Apple’s business and prospects. Specifically, the Complaint alleges that Apple failed to disclose that:

  • the U.S.-China trade war had negatively impacted demand for iPhones and Apple’s pricing power in greater China;
  • due to Apple discounting the cost of replacement batteries to make up for the Company’s prior conduct of intentionally degrading the performance of the batteries in older iPhones, the rate at which Apple customers were replacing their batteries in older iPhones, rather than purchasing new iPhones, was negatively impacting Apple’s iPhone sales growth;
  • as a result of slowing demand, Apple had slashed production orders from suppliers for the new 2018 iPhone models and cut prices to reduce inventory; and
  • Apple’s decision to withhold unit sales for iPhones and other hardware, which was a metric relevant to investors and their view of the Company’s financial performance, was designed to and would mask declines in unit sales of the Company’s flagship product.

As a result of Apple’s alleged misconduct, Apple’s stock plunged more than $15 per share, or more than 9%, from its close of $157.92 per share on January 2, 2019 to close at $142.19 per share on January 3, 2019.

If you purchased or otherwise acquired Apple stock (NASDAQ: AAPL), you may have a claim for damages. Please contact the Thornton Law Firm’s shareholder rights team at shareholder@tenlaw.com, or call 617-531-3933.

Thornton Law Firm’s securities attorneys specialize in representing individual shareholders and institutional investors in recovering damages caused by corporate wrongdoing or fraud. Its attorneys have decades of experience litigating securities cases in courts throughout the country and have a proven track record of recovering losses on behalf of shareholders.

Contact Information:

Guillaume O. Buell
Thornton Law Firm LLP
1 Lincoln Street
Boston, Massachusetts 02111

Email: gbuell@tenlaw.com
Tel: 617-531-3933

BrightView Holdings IPO Shareholder Investigation

by Guillaume Buell, Esq.

Posted on March 21, 2019

Thornton Law Firm LLP announces that it is investigating a potential securities class action on behalf of purchasers of the securities of BrightView Holdings, Inc. (NYSE ticker: BV) pursuant to, or traceable to, the registration statement and prospectus issued in connection with BrightView’s June 2018 initial public offering (“IPO”). The investigation involves possible violations of the federal securities laws by BrightView.

If you purchased BrightView Holdings, Inc. stock, you may have a claim for damages resulting from misstatements in the BrightView IPO prospectus and registration statement. If you are interested in pursuing this claim, or to discuss your legal rights, please email shareholder@tenlaw.com, or call 617-720-1333.

According to the investigation, BrightView may have made false and misleading statements in its offering documents relating to BrightView’s revenue growth, workforce, and customer contracts. As a result of disclosures from BrightView rendering these earlier statements false and misleading, BrightView’s stock dropped more than 15%, trading as low as $9.25 since August 2018.

If you purchased or otherwise acquired BrightView stock (NYSE: BV) pursuant to its IPO, you may have a claim for damages. Please contact the Thornton Law Firm’s shareholder rights team at shareholder@tenlaw.com, or call 617-720-1333.

Thornton Law Firm’s securities attorneys specialize in representing individual shareholders and institutional investors in recovering damages caused by corporate wrongdoing or fraud. Its attorneys have decades of experience litigating securities cases in courts throughout the country and have a proven track record of recovering losses on behalf of shareholders.

 

Consumer Class Actions Filed Against Airbag Maker Takata Corporation

By Garrett J. Bradley, Esq.

Posted on Nov 21, 2014

 

AirbagThe first class actions have been filed against airbag maker Takata Corporation after consumers learned that the propellants used in Takata airbags caused the airbags to explode and spew shrapnel inside cars rather than protect car passengers from danger. The airbags have been linked to at least 4 deaths and 139 injuries when they exploded with too much force. Thornton Law Firm is actively investigating claims for consumers affected by these potentially fatal defects.

Takata Corporation, TK Holdings, Inc., and Highland Industries, Inc. (Takata) have been named in multiple class actions in federal courts nationwide alleging that Takata designed, tested, manufactured and sold millions of airbags that could kill car occupants when they deploy in an accident. Another class action accuses Takata of discovering the airbag defect in 2004 and then destroying the records of those tests. Takata began using ammonium nitrate in its airbags in the late 1990s. (You may recall ammonium nitrate as one of the ingredients in the truck bomb used in the Oklahoma City bombing in 1995). Takata, which is the only airbag maker to use ammonium nitrate, claims to have favored the chemical because it allowed them to make smaller airbags, but the lawsuits claim the switch was made because ammonium nitrate is a much cheaper propellant. The class actions also name the car manufacturers because as the ultimate sellers they are responsible for any defect in the car.

Investigators from the National Highway Traffic Safety Administration (NHTSA) believe that the ammonium nitrate in the airbags is reacting with moisture from humidity, which is why the first recalls of the airbags are in more humid areas of the American south. But the recall may well expand to every Takata airbag and most major carmakers. Honda is Takata’s largest customer for airbags, but the car manufacturers known to have used Takata airbags include BMW, Ford, and Toyota. Here’s the full list of the cars involved:

Makes & Models that contain defective Takata Airbags

BMW: 

2000 – 2005 3 Series Sedan
2000 – 2006 3 Series Coupe
2000 – 2005 3 Series Sports Wagon
2000 – 2006 3 Series Convertible
2001 – 2006 M3 Coupe
2001 – 2006 M3 Convertible

Chrysler: 

2003 – 2008 Dodge Ram 1500
2005 – 2008 Dodge Ram 2500
2006 – 2008 Dodge Ram 3500
2006 – 2008 Dodge Ram 4500
2008 – Dodge Ram 5500
2005 – 2008 Dodge Durango
2005 – 2008 Dodge Dakota
2005 – 2008 Chrysler 300
2007 – 2008 Chrysler Aspen

Ford:

2004 – Ranger
2005 – 2006 GT
2005 – 2007 Mustang

General Motors: 

2003 – 2005 Pontiac Vibe
2005 – Saab 9-2X

Honda: 

2001 – 2007 Honda Accord
2001 – 2005 Honda Civic
2002 – 2006 Honda CR-V
2003 – 2011 Honda Element
2002 – 2004 Honda Odyssey
2003 – 2007 Honda Pilot
2006 – Honda Ridgeline
2003 – 2006 Acura MDX
2002 – 2003 Acura TL/CL
2005 – Acura RL

Mazda: 

2003 – 2007 Mazda6
2006 – 2007 MazdaSpeed6
2004 – 2008 Mazda RX-8
2004 – 2005 MPV
2004 – B-Series Truck

Mitsubishi: 
2004 – 2005 Lancer
2006 – 2007 Raider

Nissan: 

2001 – 2003 Nissan Maxima
2001 – 2004 Nissan Pathfinder
2002 – 2004 Nissan Sentra
2001 – 2004 Infiniti I30/I35
2002 – 2003 Infiniti QX4
2003 – 2005 Infiniti FX35/FX45

Subaru: 

2003 – 2005 Baja
2003 – 2005 Legacy
2003 – 2005 Outback
2003 – 2005 Baja
2004 – 2005 Impreza

Toyota: 

2002 – 2005 Lexus SC
2002 – 2005 Toyota Corolla
2003 – 2005 Toyota Corolla Matrix
2002 – 2005 Toyota Sequoia
2003 – 2005 Toyota Tundra

Thornton Law Firm is investigating claims on behalf of several consumers across the country who own cars which contain Takata airbags. If you believe you may have a defective Takata airbag in your car, or have suffered a personal injury from an explosively deployed Takata airbag, call our consumer class action attorneys at 888-491-9726 or tell us your story here. All consultations are free and confidential. Legal claims have short time limits so do not delay seeking legal advice.

Xarelto Anticoagulant May Be Next Nationwide MultiDistrict Litigation

Thornton Law Firm is no longer accepting new Xarelto cases.

By Marilyn T. McGoldrick, Esq.

Posted on Oct 30, 2014

janssen_logo

The Judicial Panel on MultiDistrict Litigation has been asked to certify a new MultiDistrict Litigation for the plaintiffs alleging injuries and death caused by prescription anticoagulant Xarelto. Since Xarelto was approved by the Food and Drug Administration (FDA) in 2011, doctors and patients have been reporting a number of serious side effects, including severe gastrointestinal and rectal bleeding, causing decreased hemoglobin levels requiring blood transfusions. In 2012 alone, 2,018 adverse events were recorded by the FDA’s MedWatch reporting system, including 151 deaths from uncontrolled bleeding.

Bayer_Logo.svgXarelto (generic name, rivaroxaban) is approved to prevent or treat pulmonary embolism (PE) and deep vein thrombosis (DVT). It is also prescribed to patients with atrial fibrillation to prevent strokes.Patients who have had knee or hip replacement surgery are often prescribed Xarelto to prevent the formation of blood clots. The drug is manufactured by Bayer HealthCare AG and licensed for distribution by Janssen Pharmaceuticals, Inc.

It is suspected that Xarelto leads to significant incidence of gastrointestinal and rectal bleeding that can lead to decreased hemoglobin levels requiring blood transfusions. Most serious Xarelto injuries and deaths arise from internal bleeding. Potential signs of Xarelto internal bleeding are:

  •        Prolonged bleeding from cuts
  •        Unusual swelling or bleeding
  •        Heavy or prolonged menstrual flow
  •        Frequent nose bleeds
  •        Coughing or vomiting up blood
  •        Blood in urine and/stools
  •        Unusual bruising

Xarelto is in a class of drugs called new oral anticoagulants (NOACs) which were sold as alternatives to Coumadin (warfarin) as treatments for a variety of blood clot disorders. The other drugs in the NOAC class are Pradaxa and Eliquis, and all three NOACs do not require regular blood monitoring, which is required of warfarin users. The maker of Pradaxa settled a similar class action in 2014 for $650 million dollars,

Xarelto has been heavily advertised in the media, including being the #1 product advertised in medical journals in 2013. Almost 1 million prescriptions for Xarelto were written in 2013, resulting in almost $2 billion dollars in sales.

If you or someone you love has used Xarelto and suffered serious injury resulting from internal bleeding, our Xarelto injury lawyers can help. Please call our experienced defective drug litigation attorneys at 888-341-1405 or tell us your story here for a free no obligation consultation.

Why Do They Want My Zip Code When I Use My Credit Card?

massachusetts-zip-code-map_2
By Garrett J. Bradley, Esq.

Posted on Feb 24, 2014 9:32:00 AM

The Value of Your Personal Information

Over the course of the last year, there have been a number of class action lawsuits filed against major retailers. These class actions allege that the retailers violated their duty to their customers by collecting personally identifiable information (also known as Personal Identifying Information, abbreviated PII) as they accepted credit card payment. Many, but not all, of these cases have been filed in Massachusetts, because Massachusetts has case law specifically forbidding this practice by retailers.

Some of the largest retailers in the country, and some of the best-known brand names, are currently facing class action suits. A small list of these retailers includes Bed, Bath and Beyond; Payless; Sunglasses Hut; Ann Taylor; Urban Outfitters (and Anthropologie); and, just recently, Apple. All these cases center around the retailers demanding zip code information at the time of sale.

Your personal information has value. It has a value to you personally, but also to the retailer. This information is valuable to the retailers because it helps their marketing efforts. And indeed, some of these cases allege that your personal information has been sold to third parties. If this is true, it is a violation of your privacy, and a violation of the law.

If this sounds familiar to you and is something you have personally experienced, you may have a claim and be eligible to join a class action. With over three decades of representing plaintiffs and consumers, Thornton Law Firm is well prepared to handle even the largest and most complex class action cases. If you are interested in having your potential claim reviewed, please contact us at 1-888-491-9726, or get in touch with us using our online contact form, and one of our attorneys will evaluate your claim free of charge.

Contact Us